Primary endpoint

CB Christoph R. Behem
MG Michael F. Graessler
TF Till Friedheim
RK Rahel Kluttig
HP Hans O. Pinnschmidt
AD Anna Duprée
ED E. Sebastian Debus
DR Daniel A. Reuter
SW Sabine H. Wipper
CT Constantin J. C. Trepte
request Request a Protocol
ask Ask a question
Favorite

Primary endpoint of this study was the ability of PPV to predict a mean microcirculatory flux decrease ≥ 10% following fluid administration.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A